Clinical trial
Weight Management Plus Levonorgestrel Intrauterine System or Megestrol Acetate in Endometrial Atypical Hyperplasia: Multiple Single-arm, Prospective and Open-label Clinical Study
NCT05316493 is registered in ClinicalTrials.gov with Xiaojun Chen as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Weight Management Plus Levonorgestrel Intrauterine System or Megestrol Acetate in Endometrial Atypical Hyperplasia: Multiple Single-arm, Prospective and Open-label Clinical Study
- Lead sponsor
- Xiaojun Chen
- Phase
- Phase 2/3
- Overall status
- Recruiting
- Start date
- June 13, 2022
- Completion date
- February 28, 2027
- Enrollment
- 172 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
atypical endometrial hyperplasia, fertility issues, overweight and obesity